Artal Group S.A. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2019$2,147,000
-42.7%
270,000
-10.0%
0.09%
-43.1%
Q1 2019$3,747,000
+16.0%
300,0000.0%0.15%
+27.5%
Q4 2018$3,231,000
-22.7%
300,0000.0%0.12%
+10.1%
Q3 2018$4,182,000
+13.9%
300,0000.0%0.11%
+39.7%
Q2 2018$3,672,000
-20.7%
300,0000.0%0.08%
+34.5%
Q1 2018$4,632,000300,0000.06%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$65,241,00019.83%
Octagon Capital Advisors LP 2,095,231$84,794,00016.50%
EcoR1 Capital, LLC 5,523,358$223,530,0007.12%
BVF INC/IL 3,398,067$137,520,0004.99%
PFM Health Sciences, LP 3,431,010$138,853,0004.73%
Alphabet Inc. 2,563,441$103,742,0002.50%
Boxer Capital, LLC 1,432,200$57,961,0002.25%
PARK CIRCLE Co 64,000$2,590,0002.04%
SECTORAL ASSET MANAGEMENT INC 283,210$11,462,0001.72%
DAFNA Capital Management LLC 117,200$4,743,0001.19%
View complete list of ARCUS BIOSCIENCES INC shareholders